Analyst Ratings for Jazz Pharmaceuticals PLC (JAZZ)

Updated: 2017-07-27

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) have received a consensus rating of Buy from Wall Street analysts. Last month, JAZZ received an average rating of Buy.

A buy rating was issued by 15 analysts, 0 gave an overweight rating, 3 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

JAZZ was given price targets by several analysts. The highest price target was 210, implying a possible profit of 32.38 percent. The most pessimistic price target was 144, which equates to a potential downside of -9.23 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -4.87 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.05 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -2.47 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

JAZZ has an estimated earnings growth rate of 9.61 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. JAZZ has a PEG ratio of 2.53.

In the trailing 52-weeks, JAZZ hit 163.75 at the highest peak, while it's lowest trading point was 95.80. Today's price is 65.59 percent above the 52-week low, and 3.12 percent below the high. JAZZ has a P/E ratio of 24.29. Investors typically compare the P/E ratio to a company's peers in the industry. The JAZZ value stock report compares JAZZ to some of its peers using value stock charts. The stock has a market capitalization of $9.71 billion. JAZZ's next earnings release will be on 0000-00-00, which is days away.